Join to View Full Profile
2000 Ogden AveAurora, IL 60504
Phone+1 630-978-6250
Fax+1 630-978-6869
Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ying Zhang is a radiation oncologist based in Aurora, IL. He completed his residency in Radiation Oncology at the University of Southern California/Los Angeles General Medical Center in 2014, following an internship at Loyola Medicine MacNeal Hospital. He graduated from Northwestern University The Feinberg School of Medicine in 2009. Dr. Zhang has contributed to several publications, including research on viral mRNA splicing and its role in cervical oncogenesis, as well as studies on microbial soil communities and biochar applications.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Radiation Oncology, 2010 - 2014
Loyola Medicine MacNeal HospitalInternship, Transitional Year, 2009 - 2010
Northwestern University The Feinberg School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2011 - Present
IL State Medical License 2014 - 2026
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- 8 citationsEcdysoneless Protein Regulates Viral and Cellular mRNA Splicing to Promote Cervical Oncogenesis.Sameer Mirza, Achyuth Kalluchi, Mohsin Raza, Irfana Saleem, Bhopal Mohapatra
Molecular Cancer Research. 2021-10-20 - 376 citationsQuantifying the triboelectric series.Haiyang Zou, Ying Zhang, Litong Guo, Peihong Wang, Xu He
Nature Communications. 2019-03-29 - 22 citationsIntroducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study.Feng Sun, Yang Li, Yu Chen, Wen-Long Guan, Xiangao Jiang
The European Respiratory Journal. 2019-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
